Skip to main content
logo
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.1740
-0.0240 (-12.12%)
At close: Apr 2, 2026, 4:00 PM EDT
0.1605
-0.0135 (-7.76%)
After-hours: Apr 2, 2026, 7:59 PM EDT

Virax Biolabs Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Cap
15211--
Market Cap Growth
-75.81%168.21%-82.93%---
Enterprise Value
-1.610.81-1.81.3800
Last Close Price
0.171.140.726.95--
PE Ratio
--0.70-0.21-1.36--
PS Ratio
432.58781.8411.801262.87--
PB Ratio
0.210.870.341.18--
P/TBV Ratio
0.150.750.270.81--
P/FCF Ratio
--0.96-0.26-2.59--
P/OCF Ratio
--1.08-0.30-2.59--
EV/Sales Ratio
-128.09-11.48161.52--
EV/EBITDA Ratio
--0.140.28-0.24--
EV/EBIT Ratio
--0.130.28-0.24--
EV/FCF Ratio
--0.160.25-0.33--
Debt / Equity Ratio
0.090.060.030.0200
Debt / EBITDA Ratio
-0.10-0.06-0.04-0.03--
Debt / FCF Ratio
-0.09-0.07-0.03-0.04--
Net Debt / Equity Ratio
-0.53-0.68-0.63-1.010.020.03
Net Debt / EBITDA Ratio
0.510.650.521.610.010.03
Net Debt / FCF Ratio
0.480.750.472.200.030.03
Asset Turnover
0.000.000.020.0003.98
Inventory Turnover
0.650.773.510.95012.65
Quick Ratio
9.636.3322.5510.300.020.02
Current Ratio
11.357.2725.9410.610.040.05
Return on Equity (ROE)
-107.33%-114.47%-95.98%-141.63%172.53%65.75%
Return on Assets (ROA)
-92.22%-101.20%-84.94%-116.27%-3925.59%-2071.47%
Return on Invested Capital (ROIC)
-288.87%-356.21%-860.57%775.36%168.29%61.99%
Return on Capital Employed (ROCE)
-105.73%-111.36%-91.38%-148.76%170.93%62.98%
Earnings Yield
-436.92%-142.11%-468.62%-73.77%--
FCF Yield
-456.97%-104.40%-390.11%-38.66%--
Buyback Yield / Dilution
-70.75%-85.92%-88.75%-11.15%-504.72%-154.71%
Total Shareholder Return
-70.75%-85.92%-88.75%-11.15%-504.72%-154.71%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q